Literature DB >> 24692688

Cytotoxic activity of N, N'-Bis (2-hydroxybenzyl) ethylenediamine derivatives in human cancer cell lines.

Musiliyu A Musa1, Veera L D Badisa, Lekan M Latinwo.   

Abstract

BACKGROUND: Compounds containing ethylenediamine (-NCH2CH2N-) moiety are known to exhibit antimicrobial, -fungal, -bacterial, -tuberculosis and -cancer activities.
MATERIALS AND METHODS: In the present study, we evaluated the in vitro cytotoxic activity of N,N'-bis(2-hydroxybenzyl)- (6), N,N'-bis(5-bromo-2-hydroxybenzyl)- (7) and N,N'-bis(5-chloro-2-hydroxybenzyl) (8)- ethylenediamine dihydrochlorides; and N,N'-bis(2-hydroxybenzyl)- (9), N,N'-bis(5-bromo-2-hydroxybenzyl)- (10) and N,N'-bis(5-chloro-2-hydroxybenzyl) (11)- ethylenediamine toward human lung (A549), breast (MDA-MB-231) and prostate (PC3) cancer cell lines after 24-h treatment using crystal violet dye binding assay. Effects on the cell cycle the using flow cytometry, and mitochondrial membrane potential using rhodamine-123 florescent dye were also evaluated.
RESULTS: Compounds 7 and 8 exhibit cytotoxic activity, causing cell arrest at different phases of the cell cycle and loss of mitochondrial membrane potential in the above cancer cell lines.
CONCLUSION: These findings clearly demonstrate, to our knowledge for the first time, that ethylenediamine dihydrochloride salts-compounds 7 and 8-exhibit concentration-dependent cytotoxic activity towards A549, MDA-MB-231 and PC3 cancer cell lines, which may serve as a basis for future work on novel therapeutic agents.

Entities:  

Keywords:  MMP; N,N’-Bis(2-hydroxybenzyl)ethylenediamine derivatives; cell cycle phase; cytotoxic activity; mitochondrial transmembrane potential

Mesh:

Substances:

Year:  2014        PMID: 24692688

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  In vitro evaluation of 3-arylcoumarin derivatives in A549 cell line.

Authors:  Musiliyu A Musa; Moise Y Joseph; Lekan M Latinwo; Veera Badisa; John S Cooperwood
Journal:  Anticancer Res       Date:  2015-02       Impact factor: 2.480

2.  Crystal structure of 3-[({2-[bis-(2-hy-droxy-benz-yl)amino]-eth-yl}(2-hy-droxy-benz-yl)amino)-meth-yl]-2-hydroxy-5-methyl-benzaldehyde.

Authors:  Alexandra S Fonseca; Adailton J Bortoluzzi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.